InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Discover the detailed record of transactions filed by Apel Daniel Joseph, 首席财务官. Officer active across 1 company, notably Arrowhead Pharmaceuticals, INC.. In total, 2 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €192k. Activity tracked since 6 January 2026. The latest transaction was filed on 22 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Apel Daniel Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
3,208 股@ US$70.110.0018% mcap50.0% 占其流量Common StockSEC:0000879407-26-000039:0
75,000 股0Common StockSEC:0002081169-26-000002:0
2 条申报中的 2 条
About Apel Daniel Joseph
Daniel Joseph Apel is the Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. He oversees financial operations and contributes to the overall strategy of the company.
